Revenue OutlookThe reduction in the FY25 topline outlook is caused by the DHA extension, as the previous forecast had assumed expansion revenues in the second half of FY25.
Subscription RevenueManagement anticipates subscription revenue to be 53% of 2025 revenues, down from the prior expectation of nearly 60%.
Topline Guidance RevisionA negative topline guidance revision stems from the extension of the DHA contract for 2026, which will exclude automated care and behavioral health components due to budget constraints.